Avai Bio, Inc.
AVAI
Get informed when a big investor buys or sells
+ FollowMarket Cap$90.31M
Close$
$-0.01
111.2% downside
Current Fair Value
111.2% downsideOvervalued by 111.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $90.31 Million |
|---|---|
| Enterprise Value | $92.51 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 0.87 |
| Outstanding Shares | 153,916,565 |
Return
| Return on Equity | 56.29% |
|---|---|
| Return on Assets | -229.11% |
| Return on Invested Capital | 18.94% |
Valuation & Multiples
| P/E Ratio | -8.98 |
|---|---|
| PEG | -67.91 |
| Price to Sales | - |
| Price to Book Ratio | -0.11 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -151.58 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -0.71 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Avai Bio, Inc.
1 employees
CEO: Chris Winter Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and ma...